(September 11, 2015, 11:16 AM EDT) -- WASHINGTON, D.C. — Promega Corp. asserts in an opposition brief filed Aug 26 that the U.S. Supreme Court should not review a lower court’s interpretation and application of an infringement statute in a ruling that reversed an order vacating Promega’s $52 million victory in a patent and licensing dispute over gene-testing technology (Life Technologies Corp., et al. v. Promega Corp., No. 14-1538, U.S. Sup.)....